Physician

Casey D. Curtis, M.D.

According to 2025 Medicare claims, Casey Curtis, M.D. (NPI: 1457588642) practices allergy/immunology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU OTOLARYNGOLOGY HEAD AND NECK SURGERY LLC (NPI: 1861449407; TIN: 202288402) and primary practice location at 43212-3153. Curtis is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Curtis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 1,393 HCPCS/CPT codes, and received $21,847 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 903 prescription claims across 137 beneficiaries totaling $956,719 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 228 claims. Open Payments data shows 4 records totaling $9,744. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $12,697 and ending at $21,847. Concurrently, Part D prescription costs have risen steadily, from $50,276 to $956,719. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $548 to $4,092.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	68	1,093	$12,697
2016	87	1,792	$19,925
2017	117	2,009	$21,867
2018	144	2,236	$26,242
2019	152	2,008	$24,117
2020	133	1,661	$18,312
2021	161	2,311	$24,339
2022	146	2,503	$24,897
2023	150	1,993	$23,154
2024	148	1,393	$21,847

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	157	$50,276
2016	51	134	$49,243
2017	74	233	$102,838
2018	91	364	$271,072
2019	115	462	$457,517
2020	127	548	$330,039
2021	130	693	$474,917
2022	154	842	$1,024,428
2023	141	833	$973,058
2024	137	903	$956,719

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	28	$33,451
2019	N/R	62	$79,988
2020	N/R	83	$121,264
2021	N/R	157	$295,023
2022	N/R	170	$258,001
2023	N/R	197	$313,144
2024	N/R	228	$341,990

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	44	44	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	63	91	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	11	11	$54
95117	Professional service for multiple injections of allergen	18	126	$8
95115	Professional service for single injection of allergen	13	59	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	57	1,596	$315,377
Panzyga	Immun Glob G(Igg)-Ifas/Glycine	39	390	$99,201
Cuvitru	Immun Glob G(Igg)/Gly/Iga Ov50	15	420	$97,752
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	47	1,316	$83,815
Dupixent Syringe	Dupilumab	15	420	$82,552

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	61	$267,046
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	13	$41,948
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	12	$28,916
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	36	$2,853
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	85	$949

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$2,189	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$7,555	GlaxoSmithKline, LLC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Casey D. Curtis, M.D.?

Tedicare shows public-source Medicare data for Casey D. Curtis, M.D. (NPI 1457588642), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Casey D. Curtis, M.D. have ACO affiliation data?

Casey D. Curtis, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Casey D. Curtis, M.D.?

Casey D. Curtis, M.D. is linked to OSU OTOLARYNGOLOGY HEAD AND NECK SURGERY LLC (billing NPI 1861449407) in the available physician profile data.

Does Casey D. Curtis, M.D. have Open Payments data?

Casey D. Curtis, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.